Randomized phase III trial of amrubicin/cisplatin versus etoposide/cisplatin as first-line treatment for extensive small-cell lung cancer.
Sun Y, Cheng Y, Hao X, Wang J, Hu C, Han B, Liu X, Zhang L, Wan H, Xia Z, Liu Y, Li W, Hou M, Zhang H, Xiu Q, Zhu Y, Feng J, Qin S, Luo X.
Sun Y, et al. Among authors: liu y, liu x.
BMC Cancer. 2016 Apr 9;16:265. doi: 10.1186/s12885-016-2301-6.
BMC Cancer. 2016.
PMID: 27061082
Free PMC article.
Clinical Trial.